Imunon, Inc.
Developing DNA-based immunotherapies for oncology and infectious diseases.
IMNN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 997 LENOX DRIVE, 8648 LAWRENCEVILLE
- Website:
- https://imunon.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Imunon, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies and vaccines that harness the body's immune system. The company creates proprietary immunology and DNA-based platforms to advance a pipeline of nucleic acid-based therapies. Its primary development focus is on treatments for difficult-to-treat conditions, particularly in oncology, with a clinical program for ovarian cancer, and infectious diseases. As a fully integrated company, Imunon's capabilities span the full range of drug development from research and discovery to manufacturing. The company was formerly known as Celsion Corp.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Imunon, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Imunon, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Imunon, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
